Share

August 20, 2019; 93 (8) Corrections

INTREPAD

A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease

First published August 19, 2019, DOI: https://doi.org/10.1212/WNL.0000000000007919
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
248

Share

See original article:

Article Information

vol. 93 no. 8 371
DOI: 
https://doi.org/10.1212/WNL.0000000000007919
PubMed: 
31427496
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published August 19, 2019.
Copyright & Usage: 
© 2019 American Academy of Neurology

Author Disclosures

    View Full Text

    Article usage

    Article usage: August 2019 to April 2022

    AbstractFullPdfSource
    Aug 2019219440Highwire
    Sep 201904318Highwire
    Oct 20190279Highwire
    Nov 20192278Highwire
    Dec 20190145Highwire
    Jan 2020092Highwire
    Feb 20200187Highwire
    Mar 20200147Highwire
    Apr 20200256Highwire
    May 2020053Highwire
    Jun 20201194Highwire
    Jul 20200137Highwire
    Aug 2020072Highwire
    Sep 20202135Highwire
    Oct 20200195Highwire
    Nov 20200146Highwire
    Dec 20202138Highwire
    Jan 2021086Highwire
    Feb 2021074Highwire
    Mar 20210104Highwire
    Apr 20212141Highwire
    May 202101713Highwire
    Jun 2021154Highwire
    Jul 2021158Highwire
    Aug 20212135Highwire
    Sep 2021097Highwire
    Oct 20210616Highwire
    Nov 20210822Highwire
    Dec 20210122Highwire
    Jan 20220124Highwire
    Feb 20221134Highwire
    Mar 2022052Highwire
    Apr 2022174Highwire

    Disputes & Debates: Rapid online correspondence

    No comments have been published for this article.
    Comment

    REQUIREMENTS

    If you are uploading a letter concerning an article:
    You must have updated your disclosures within six months: http://submit.neurology.org

    Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

    If you are responding to a comment that was written about an article you originally authored:
    You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
    and apply to letter.

    Submission specifications:

    • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
    • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
    • Submit only on articles published within 6 months of issue date.
    • Do not be redundant. Read any comments already posted on the article prior to submission.
    • Submitted comments are subject to editing and editor review prior to posting.

    More guidelines and information on Disputes & Debates

    Compose Comment

    More information about text formats

    Plain text

    • No HTML tags allowed.
    • Web page addresses and e-mail addresses turn into links automatically.
    • Lines and paragraphs break automatically.
    Author Information
    NOTE: The first author must also be the corresponding author of the comment.
    First or given name, e.g. 'Peter'.
    Your last, or family, name, e.g. 'MacMoody'.
    Your email address, e.g. higgs-boson@gmail.com
    Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
    Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
    Publishing Agreement
    NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    Vertical Tabs

    You May Also be Interested in

    Back to top
    Advertisement

    Related Articles

    Alert Me